Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VeraFlo with Prontosan for infected lower extremity fractures
NCT02621073Terminated
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of polihexanide in surgical site infection (SSI). Primary endpoint: Bacterial Load at 4 weeks. Started Nov 2015; status: terminated.
02
Drugs
polihexanide
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02621073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02621073.